Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2021-05-28 Proxy Solicitation & In…
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
Proxy Solicitation & Information Statement 2021
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is related to the company's Annual Meeting of Stockholders, detailing proposals to be voted on, including election of directors, approval of amendments to the certificate of incorporation, ratification of auditors, executive compensation advisory votes, and adjournment of the meeting. The document includes detailed information about the meeting, voting instructions, board nominees, governance, and compensation. This matches the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document is not an announcement of a report, nor is it a full annual report or earnings release. It is a comprehensive proxy statement for the annual meeting.
2021-05-28 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content specifically discusses the rescheduling of the company's Annual Meeting of Stockholders and updates related to proxy materials and stockholder proposal deadlines. It does not contain financial statements or detailed financial performance data. The document is relatively short (4301 characters) and serves as an announcement of changes related to the Annual Meeting and proxy materials, not the meeting materials themselves or the voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2021-05-27 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-24 English
Regulatory Filings 2021
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 Notification of Late Filing submitted to the SEC by NanoVibronix, Inc. It specifically states that the company is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021, within the prescribed time period and requests an extension. The document does not contain the actual financial statements or substantive financial data of the 10-Q report but is rather a notification about the delay in filing that report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document related to the filing process and not the report itself.
2021-05-17 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the submission of matters to a vote of security holders at a special meeting, detailing the voting results on proposals related to the company's capital stock and amendments to the certificate of incorporation. This corresponds to the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides official results from shareholder votes at a general meeting. The document is about 5895 characters, contains detailed voting results, and is not merely an announcement of a report or a proxy solicitation. Therefore, the correct classification is DVA with high confidence.
2021-05-10 English
Proxy Solicitation & Information Statement 2021
Proxy Solicitation & Information Statement
2021-04-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.